skip to Main Content
Further Clarity On Access To Compassionate Use Program For Risdiplam.

Further Clarity on Access to Compassionate Use Program for Risdiplam.

We have received further clarity statement from the NHS England Clinical Panel for nusinersen with regards to access compassionate program for Risdiplam.

It is important to note that Nusinersen must be tried as a priority, before access to Risdiplam should be considered. Please see link to the document below containing the full statement

Statement on risdiplam compassionate use programme

Back To Top